#3798
Intra-arterial PRRT – A prospective clinical study in NET patients with hepatic metastases
Introduction:
Liver metastases of neuro-endocrine tumors have a significant impact on survival of patients treated with 177Lu-DOTATATE.
Conference:
Presenting Author:
Authors:
Ebbers S,
Barentsz M,
de Vries-Huizing D,
Versleijen M,
Klompenhouwer L,
Keywords:
PRRT,
intra-arterial,
lutetium,
neuroendocrine tumor,
peptide receptor radionuclide therapy,
treatment response,
#1099
Niacin (vitamin B3) Suppletion in Patients with Serotonin Producing Neuroendocrine Tumors
Introduction:
Tryptophan is the precursor of serotonin and niacin (vitamin B3), critical for normal cellular metabolism. Tryptophan and niacin can be deficient in patients with serotonin producing neuroendocrine tumors (NETs). Niacin deficiency can lead to symptoms including pellagra.
Conference:
12th Annual ENETSConcerence (2015)
Presenting Author:
Walenkamp A
Authors:
Bouma G,
Van Faassen M,
Kats-Ugurlu G,
De Vries E,
Kema I,
Keywords:
NET,
Serotonin,
Niacin,
N1-methylnicotinamide.,
#881
Web-Based Tailored Information and Support for Patients with a Neuroendocrine Tumor
Introduction:
Patients with neuroendocrine tumors (NET) frequently experience physical and psychosocial complaints. Optimal patient information can form an essential aspect of supportive care. To give NET patients continuous access to information, we developed a web-based tailored information and support system.
Conference:
11th Annual ENETSConcerence (2014)
Presenting Author:
Authors:
Bouma G,
De Vries E,
Wymenga M,
Walenkamp A,
Keywords:
neuroendocrine,
tumor,
information,
support,
distress,
quality,
empowerment,
